Metraipolis › archive › dc_640a6cbb72dd

Metastasis-Directed Therapy Versus Systemic Therapy in Oligometastatic Endometrial Carcinoma Recurrence: A Population-Based Registry Analysis — Europe PMC PMID:42938913

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42938913
DOI
10.3390/cancers18203382
License (as archived)
solo-consultazione
Archived
2026-11-01T08:10:04.474Z
SHA-256 of the archived text
017813c1daa59e1a9506be33c5f79c80424f735e6a002614da777716e3d209ec
Stable URL of this page
https://metraipolis.com/documento/dc_640a6cbb72dd

How to cite

Metastasis-Directed Therapy Versus Systemic Therapy in Oligometastatic Endometrial Carcinoma Recurrence: A Population-Based Registry Analysis — Europe PMC PMID:42938913 — Europe PMC (en), https://europepmc.org/article/MED/42938913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_640a6cbb72dd (Metraipolis archive dc_640a6cbb72dd, sha256 017813c1daa59e1a9506be33c5f79c80424f735e6a002614da777716e3d209ec)
BibTeX
@misc{dc640a6cbb72dd,
  title = {Metastasis-Directed Therapy Versus Systemic Therapy in Oligometastatic Endometrial Carcinoma Recurrence: A Population-Based Registry Analysis — Europe PMC PMID:42938913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42938913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_640a6cbb72dd; sha256 017813c1daa59e1a9506be33c5f79c80424f735e6a002614da777716e3d209ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42938913. Agents can read the archived copy with the MCP tool read_document.